Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1996 2
1997 6
1998 4
1999 7
2000 10
2001 12
2002 2
2003 2
2004 6
2005 6
2006 1
2007 3
2008 1
2009 3
2010 2
2011 4
2012 6
2013 6
2014 7
2015 2
2016 2
2017 2
2018 6
2019 5
2020 1
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 21952639

103 results
Results by year
Filters applied: . Clear all
Page 1
NIRF constitutes a nodal point in the cell cycle network and is a candidate tumor suppressor.
Mori T, Ikeda DD, Fukushima T, Takenoshita S, Kochi H. Mori T, et al. Cell Cycle. 2011 Oct 1;10(19):3284-99. doi: 10.4161/cc.10.19.17176. Epub 2011 Oct 1. Cell Cycle. 2011. PMID: 21952639 Free PMC article.
NIRF/UHRF2 occupies a central position in the cell cycle network and allows coupling with the epigenetic landscape.
Mori T, Ikeda DD, Yamaguchi Y, Unoki M; NIRF Project. Mori T, et al. FEBS Lett. 2012 Jun 4;586(11):1570-83. doi: 10.1016/j.febslet.2012.04.038. Epub 2012 Apr 30. FEBS Lett. 2012. PMID: 22673569 Free article. Review.
UHRF2, another E3 ubiquitin ligase for p53.
Bai L, Wang X, Jin F, Yang Y, Qian G, Duan C. Bai L, et al. Biochem Biophys Res Commun. 2012 Sep 7;425(4):908-11. doi: 10.1016/j.bbrc.2012.08.009. Epub 2012 Aug 9. Biochem Biophys Res Commun. 2012. PMID: 22902639 Retracted.
Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E, Peschos D, Goussia A, Mittari E, Charalabopoulos K, Michael M, Salmas M, Vougiouklakis T, Assimakopoulos D, Agnantis NJ. Ioachim E, et al. J Exp Clin Cancer Res. 2004 Jun;23(2):277-83. J Exp Clin Cancer Res. 2004. PMID: 15354413
Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours.
Gugger M, Kappeler A, Vonlanthen S, Altermatt HJ, Ris HB, Lardinois D, Borner MM, Heighway J, Betticher DC. Gugger M, et al. Lung Cancer. 2001 Aug-Sep;33(2-3):229-39. doi: 10.1016/s0169-5002(01)00196-9. Lung Cancer. 2001. PMID: 11551418
Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression.
Gorgoulis VG, Zacharatos P, Kotsinas A, Liloglou T, Kyroudi A, Veslemes M, Rassidakis A, Halazonetis TD, Field JK, Kittas C. Gorgoulis VG, et al. Am J Pathol. 1998 Dec;153(6):1749-65. doi: 10.1016/S0002-9440(10)65690-8. Am J Pathol. 1998. PMID: 9846966 Free PMC article.
RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway.
Wang H, Yang Z, Liu C, Huang S, Wang H, Chen Y, Chen G. Wang H, et al. Biochem Biophys Res Commun. 2014 Nov 7;454(1):71-7. doi: 10.1016/j.bbrc.2014.10.023. Epub 2014 Oct 14. Biochem Biophys Res Commun. 2014. PMID: 25445601
Retinoblastoma protein in human renal cell carcinoma in relation to alterations in G1/S regulatory proteins.
Hedberg Y, Ljungberg B, Roos G, Landberg G. Hedberg Y, et al. Int J Cancer. 2004 Mar 20;109(2):189-93. doi: 10.1002/ijc.11665. Int J Cancer. 2004. PMID: 14750168 Free article.
HOXB13 contributes to G1/S and G2/M checkpoint controls in prostate.
Hamid SM, Cicek S, Karamil S, Ozturk MB, Debelec-Butuner B, Erbaykent-Tepedelen B, Varisli L, Gonen-Korkmaz C, Yorukoglu K, Korkmaz KS. Hamid SM, et al. Mol Cell Endocrinol. 2014 Mar 5;383(1-2):38-47. doi: 10.1016/j.mce.2013.12.003. Epub 2013 Dec 8. Mol Cell Endocrinol. 2014. PMID: 24325868
103 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback